Wild-Type KRAS and NRAS Colorectal Cancer
Colorectal cancer (CRC) represents a significant global health burden, ranking among the top three most commonly diagnosed cancers worldwide. Among its molecular determinants, RAS oncogenes, particularly KRAS and NRAS, play a pivotal role in tumor behavior and treatment responsiveness. Patients with wild-type KRAS and NRAS colorectal cancer, which denotes the absence of mutations in these